See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
This report presents a description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and 31 July 2024.
Seasonal influenza and COVID-19 vaccination uptake for risk groups such as the elderly were sub-optimal in several EU/EEA Member States during the 2023-2024 season, according to two reports released today by the European Centre for Disease Prevention and Control (ECDC).
This focused after-action review (AAR) investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron variant was circulating and schools remained open.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 November 2024 and includes updates on avian influenza, Middle East respiratory virus syndrome, West Nile virus, dengue, mpox, Marburg virus disease, and an overview or respiratory virus epidemiology in the EU/EEA.
The French National Sexual Health Strategy (SNSS) launched in 2017 integrates HIV into broader sexual health priorities. The European Centre for Disease Prevention and Control (ECDC) was asked to review the system to benchmark it against other European systems and provide recommendations for its improvement. Data for the assessment were collected through a desk review, benchmarking exercises, and stakeholder interviews.
This survey report provides information that can support national public health institutes and policy-makers with the development of seasonal influenza vaccination programmes and supporting activities.